Long-term maintenance therapy with proton-pump inhibitors (PPIs) was shown to be associated with an increased risk for esophageal cancer, even in patients taking PPIs for indications not previously associated with this cancer risk, according to results from a new study from Sweden.
https://www.medscape.com/viewarticle/893399
Long-term PPI Use and Increased Esophageal CA Risk